Principal Investigator
Eugene Schiff
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240986
Clinical Trial Summary
A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated nonalcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu